ENTRY       D11067            Mixture   Drug
NAME        Ertugliflozin and metformin;
            Segluromet (TN)
PRODUCT     SEGLUROMET (A-S Medication Solutions)
            SEGLUROMET (A-S Medication Solutions)
            SEGLUROMET (A-S Medication Solutions)
            SEGLUROMET (Merck Sharp & Dohme LLC)
COMPONENT   (Ertugliflozin pidolate [DR:D11043] | Ertugliflozin [DR:D10313]), (Metformin hydrochloride [DR:D00944] | Metformin [DR:D04966])
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG03034  Combination of metformin and SGLT2 inhibitor
REMARK      ATC code: A10BD23
            Product: D11067<US>
EFFICACY    Antidiabetic
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BD Combinations of oral blood glucose lowering drugs
                 A10BD23 Metformin and ertugliflozin
                  D11067  Ertugliflozin and metformin &lt;US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Combinations
               Ertugliflozin/ Metformin Hydrochloride
                D11067  Ertugliflozin and metformin
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG03034  Combination of metformin and SGLT2 inhibitor
                D11067  Ertugliflozin and metformin
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D11067  Ertugliflozin and metformin
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11067
DBLINKS     PubChem: 375581014
///
